Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

  • Britain's medicines regulator approved the use of Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine in children between six and 11 years.
  • The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was granted after Moderna's vaccine, known as Spikevax, met the required safety, quality, and effectiveness standards.
  • Read Next: Why Did Moderna Recall Thousands Of COVID-19 Vaccine Doses In Europe?
  • This approval considers the extension to use in children aged 6 to 11 years already approved by the European Medicines Agency in March. The original Great Britain license for Spikevax in adults was approved by relying on the EU decision.
  • The approval comes hours after the regulator approved Valneva SE's (NASDAQ:VALNCOVID-19 vaccine for adults up to 50 years.
  • Price Action: MRNA shares are down 2.24% at $165.86 during the market session on the last check Thursday.
  • Photo by mufidpwt via Pixaby
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.